VEEV - Veeva down 10% following updated fiscal 2025 revenue guidance
2024-05-30 17:59:42 ET
More on Veeva Systems
- Veeva Systems: Stellar Growth And Profitability Profile
- Veeva Systems: Strong Reasons To Buy And Hold The Shares
- Veeva: Clinical Trial Platform Monopoly With Huge Untapped Opportunities
- Veeva Systems Non-GAAP EPS of $1.50 beats by $0.08, revenue of $650.35M beats by $8.36M
- Veeva Systems Q1 2025 Earnings Preview